Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

医学 心房颤动 导管消融 内科学 心脏病学 药品 药物治疗 心脏消融 麻醉 冲程(发动机) 烧蚀 药理学 机械工程 工程类
作者
Douglas L. Packer,Daniel B. Mark,Richard A. Robb,Kristi H. Monahan,Tristram D. Bahnson,Jeanne E. Poole,Peter A. Noseworthy,Yves Rosenberg,Neal O. Jeffries,L. Brent Mitchell,Greg C. Flaker,Evgeny A. Pokushalov,Alexander B. Romanov,Thomas Jared Bunch,Georg Noelker,Ardashev Av,Amiran Sh. Revishvili,David J. Wilber,Riccardo Cappato,Karl‐Heinz Kück
出处
期刊:JAMA [American Medical Association]
卷期号:321 (13): 1261-1261 被引量:1520
标识
DOI:10.1001/jama.2019.0693
摘要

Importance: Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF), but its effects on long-term mortality and stroke risk are uncertain. Objective: To determine whether catheter ablation is more effective than conventional medical therapy for improving outcomes in AF. Design, Setting, and Participants: The Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation trial is an investigator-initiated, open-label, multicenter, randomized trial involving 126 centers in 10 countries. A total of 2204 symptomatic patients with AF aged 65 years and older or younger than 65 years with 1 or more risk factors for stroke were enrolled from November 2009 to April 2016, with follow-up through December 31, 2017. Interventions: The catheter ablation group (n = 1108) underwent pulmonary vein isolation, with additional ablative procedures at the discretion of site investigators. The drug therapy group (n = 1096) received standard rhythm and/or rate control drugs guided by contemporaneous guidelines. Main Outcomes and Measures: The primary end point was a composite of death, disabling stroke, serious bleeding, or cardiac arrest. Among 13 prespecified secondary end points, 3 are included in this report: all-cause mortality; total mortality or cardiovascular hospitalization; and AF recurrence. Results: Of the 2204 patients randomized (median age, 68 years; 37.2% female; 42.9% had paroxysmal AF and 57.1% had persistent AF), 89.3% completed the trial. Of the patients assigned to catheter ablation, 1006 (90.8%) underwent the procedure. Of the patients assigned to drug therapy, 301 (27.5%) ultimately received catheter ablation. In the intention-to-treat analysis, over a median follow-up of 48.5 months, the primary end point occurred in 8.0% (n = 89) of patients in the ablation group vs 9.2% (n = 101) of patients in the drug therapy group (hazard ratio [HR], 0.86 [95% CI, 0.65-1.15]; P = .30). Among the secondary end points, outcomes in the ablation group vs the drug therapy group, respectively, were 5.2% vs 6.1% for all-cause mortality (HR, 0.85 [95% CI, 0.60-1.21]; P = .38), 51.7% vs 58.1% for death or cardiovascular hospitalization (HR, 0.83 [95% CI, 0.74-0.93]; P = .001), and 49.9% vs 69.5% for AF recurrence (HR, 0.52 [95% CI, 0.45-0.60]; P < .001). Conclusions and Relevance: Among patients with AF, the strategy of catheter ablation, compared with medical therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest. However, the estimated treatment effect of catheter ablation was affected by lower-than-expected event rates and treatment crossovers, which should be considered in interpreting the results of the trial. Trial Registration: ClinicalTrials.gov Identifier: NCT00911508.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
年轻可愁完成签到 ,获得积分10
刚刚
七颗小葡萄完成签到,获得积分10
刚刚
一定按时睡觉完成签到 ,获得积分10
刚刚
往昔如金发布了新的文献求助10
刚刚
科研通AI2S的应助被拼搏的似狮采纳,获得10
刚刚
xiaochaoge完成签到,获得积分10
刚刚
知足肠乐完成签到,获得积分0
1秒前
彪yu完成签到,获得积分10
1秒前
1秒前
知知完成签到,获得积分10
1秒前
1秒前
彩色大碗完成签到,获得积分10
1秒前
way_oz完成签到,获得积分10
2秒前
2秒前
银河系小熊完成签到,获得积分10
2秒前
小蘑菇的应助被2319374525采纳,获得10
2秒前
沙海冬完成签到,获得积分10
2秒前
唐僧完成签到,获得积分10
2秒前
3秒前
you完成签到 ,获得积分10
3秒前
haohao完成签到,获得积分10
3秒前
3秒前
孤梦落雨完成签到,获得积分10
3秒前
有魅力的白玉完成签到 ,获得积分10
3秒前
哈呼呼发布了新的文献求助10
3秒前
QDmaster完成签到,获得积分10
3秒前
3秒前
hqt完成签到,获得积分10
4秒前
DeepSleep1145完成签到,获得积分10
4秒前
他说发布了新的文献求助10
4秒前
菲菲宋完成签到,获得积分20
4秒前
孙婉莹完成签到,获得积分10
4秒前
4秒前
4秒前
Heimdall完成签到,获得积分10
5秒前
sflll完成签到,获得积分10
6秒前
甜甜奶黄包完成签到,获得积分10
6秒前
繁花完成签到,获得积分10
6秒前
迅速的访彤完成签到,获得积分10
6秒前
风吹凉完成签到,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180407
求助须知:如何正确求助?哪些是违规求助? 9570403
关于积分的说明 21811831
捐赠科研通 7776452
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557499
邀请新用户注册赠送积分活动 2479105